Conformis Inc Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense
Amortization of debt discount
Stock-based compensation expense
Unrealized foreign exchange loss
Non-cash lease expense
Provision for bad debts on trade receivables
Goodwill impairment
Impairment of long-term assets
Disposal of long-term assets
Gain on forgiveness of PPP loan
Loss on extinguishment of debt
Non-cash interest expense
Accretion on investments
Deferred tax
Changes in operating assets and liabilities:
Accounts receivable
Royalty and licensing receivable
Inventories
Prepaid expenses and other assets
Accounts payable, accrued expenses, and other liabilities
Contract liability
Other long-term liabilities

Net cash used in operating activities
Advance on research and development

Net cash used in operating activities
Cash flows from investing activities:
Acquisition of property and equipment
Business acquisition, net of cash acquired
(Increase) decrease in restricted cash
Purchase of investments
Maturity of investments
Net cash provided/(used) in investing activities
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from exercise of common stock options
Proceeds from exercise of common stock warrants
Proceeds from exercise of pre-funded warrants
Debt issuance costs
Loss on extinguishment of debt
Proceeds from issuance of debt
Payments on long-term debt
Net proceeds from issuance of common stock
Net cash provided by financing activities

Decrease in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Issuance of common stock and pre-funded warrants under registered direct offering, net
Net cash provided by financing activities
Foreign exchange effect on cash and cash equivalents
(Decrease) increase in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash beginning of period
Cash, cash equivalents, and restricted cash end of period
Supplemental information:
Cash paid for interest
Non-cash investing and financing activities
Issuance of common stock for business acquisition
Issuance of common stock for equity financing
Operating leases right-of-use assets obtained in exchange for lease obligations

Comments